Načítá se...
Refractory autoimmune haemolytic anaemia following allogenic haematopoietic stem cell transplantation: successful treatment of rituximab
OBJECTIVE: To investigate the effectiveness and safety of rituximab in treating autoimmune haemolytic anaemia (AIHA) after allogeneic haematopoietic stem cell transplantation (allo-HSCT). METHODS: Patients with refractory AIHA following allo-HSCT were treated once-weekly with rituximab 375 mg/m(2) f...
Uloženo v:
| Vydáno v: | J Int Med Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683942/ https://ncbi.nlm.nih.gov/pubmed/31280646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519855593 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|